"The agreement allows CryoLife to distribute existing and newly processed non-valved cardiac conduits and patches, saphenous veins, femoral veins and arteries, and aorto-iliac arteries for specified medically urgent uses when alternative treatments have been exhausted or are unavailable. "
This is emergency use for some tissues (the ones in short supply). Most of the allografts recalled REMAIN recalled.
FDA did the same thing for heart valves. The heart valves were not recalled (yet) because there was not enough available from alternate sources (yet).